Rezdiffra is already approved and available in the US for adults with noncirrhotic MASH who have moderate to advanced liver ...

Argenx (NASDAQ: ARGX) is one of the best biotech stocks to invest in now. On June 20, Argenx announced that the European ...

Greece has made progress since the crisis, but external financing risks persist without deeper domestic reforms, a new study ...

European countries are jointly working on a deterrence strategy against any external aggression, which is expected to be ...